Rationale: p120-catenin (p120) is an armadillo family protein that binds to the cytoplasmic domain of classical cadherins and prevents cadherin endocytosis. The role of p120 in vascular development is unknown. Objective: The purpose of this study is to examine the role of p120 in mammalian vascular development by generating a conditionally mutant mouse lacking endothelial p120 and determining the effects of the knockout on vasculogenesis, angiogenic remodeling, and the regulation of endothelial cadherin levels. Methods and Results: A conditional Cre/loxP gene deletion strategy was used to ablate p120 expression, using the Tie2 promoter to drive endothelial Cre recombinase expression. Mice lacking endothelial p120 died embryonically beginning at embryonic day 11.5. Major blood vessels appeared normal at embryonic day 9.5. However, both embryonic and extraembryonic vasculature of mutant animals were disorganized and displayed decreased microvascular density by embryonic day 11.5. Importantly, both vascular endothelial cadherin and N-cadherin levels were significantly reduced in vessels lacking p120. This decrease in cadherin expression was accompanied by reduced pericyte recruitment and hemorrhaging. Furthermore, p120-null cultured endothelial cells exhibited proliferation defects that could be rescued by exogenous expression of vascular endothelial cadherin. Conclusions: These findings reveal a fundamental role for p120 in regulating endothelial cadherin levels during vascular development, as well as microvascular patterning, vessel integrity, and endothelial cell proliferation. Loss of endothelial p120 results in lethality attributable to decreased microvascular density and hemorrhages. (Circ Res. 2010; 106:941-951.)
V ascular endothelial cells line blood vessels and regulate the movement of solutes, fluids, and cells between the plasma and tissue extracellular space. In addition, endothelial cells are active participants in inflammatory responses and wound healing and undergo dynamic alterations in cell surface adhesive potential, migratory activity, and proliferative capacity. Endothelial cell adhesion molecules have long been appreciated to play key roles in vascular biology and pathophysiology. In particular, vascular endothelial (VE)-cadherin has been implicated in the regulation of vascular barrier function, [1] [2] [3] inflammatory cell transmigration, 4 and endothelial cell proliferation and morphogenesis during neovascularization. 5 VE-cadherin mediates adhesion through homophilic, calcium-dependent interactions between neighboring endothelial cells and couples this adhesive activity to the actin cytoskeleton at the adherens junction. 1, 6 Cytoplasmic interactions between the cadherin tail and armadillo family proteins such as ␤-catenin, plakoglobin, and p120-catenin (p120) are thought to regulate cadherin adhesive function. 3, 7 ␤-Catenin and plakoglobin have been shown to mediate associations between cadherins and the cytoskeleton, 8, 9 although the precise molecular interactions that lead to this linkage remain unclear. p120-catenin binds to the juxtamembrane domain of classical cadherins. 10, 11 First discovered as a Src phosphorylation substrate, 12 p120 was later shown to be an armadillo family protein. 13 A central function of p120 is to regulate cadherin stability. 14 Previous studies have shown that p120 prevents clathrin-dependent endocytosis of VE-cadherin and thus stabilizes VE-cadherin at the plasma membrane. [15] [16] [17] Through this activity, cellular levels of p120 act as a set point, or rheostat, for control of cell surface and steady state cadherin expression levels. 18 -20 Additionally, p120 is an important regulator of members of the Rho family of small GTPases, 21 and functions in the nucleus to regulate transcription through interactions with Kaiso. 22 Although many of these activities of p120 have been elucidated using in vitro studies, the functions of p120 in vivo are less clear. In Drosophila 23, 24 and C. elegans, 25 p120 plays a supporting but nonessential role in cadherin stability and cell adhesion. However, global loss of p120 is lethal in vertebrates, resulting in severe morphogenetic defects in Xenopus, 26, 27 and embryonic lethality in mice 28 and zebrafish. 29 Tissue-specific p120 ablation in the mouse likewise results in a variety of defects. The conditional knockout of p120 in the salivary gland using the Cre/LoxP system resulted in disorganized ducts, reductions in E-cadherin levels, and the formation of epithelial masses that followed a cancer-like growth progression. 30 Conditional p120 knockout in forebrain neuroepithelia resulted in reduced density of neuronal spines and synapses, an effect owing more to the dysregulation of Rho GTPases than changes in N-cadherin levels. 31 Furthermore, an epidermal conditional p120 knockout mouse displayed a chronic inflammatory response caused by nuclear factor B activation, also likely downstream of altered regulation of Rho family GTPases. 32 These and other unpublished results demonstrate that tissue-specific ablation of p120 produces a wide range of phenotypes with differing degrees of severity.
The role of p120 in mammalian vascular development has not been addressed. To explore the functions of this junctional protein in vivo, a conditional mouse knockout approach was used to ablate endothelial p120 expression. The results presented here demonstrate that p120 is essential for vascular development and remodeling and that its conditional endothelial ablation results in embryonic lethality. Mice lacking endothelial p120 exhibit a reduction in VE-cadherin and N-cadherin levels, as well as hemorrhages, decreased microvascular density, reduced pericyte coverage, and disorganized vascular networks in both embryonic and extraembryonic tissues. These findings reveal a fundamental role for p120 in vascular development and endothelial function in vivo.
Methods
Mice with LoxP sites in introns 2 and 8 of the p120 gene were generated as described previously. 30 Tie2-Cre-expressing C57BL/6 mice were obtained from The Jackson Laboratory (no. 004128).
Detailed descriptions of tissue processing, antibodies used for immunofluorescence, microscopy and image quantitation, primary cell isolation, and cultured cell experiments are provided in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
Results

Loss of Endothelial p120-Catenin Is Embryonic Lethal
A conditional gene ablation strategy was used to define the function of p120 in mouse vascular development. Mice harboring a LoxP-flanked allele of the p120 gene 30 were crossed with transgenic mice expressing Cre recombinase driven by the Tie2 promoter (Online Figure I, A) , resulting in endothelial Cre expression beginning at embryonic day (E)7.5. 33 Fewer than expected pups harboring the p120 flox/flox ; Cre ϩ (conditional mutant) genotype were observed in litters (Online Figure I, B) , suggesting that deletion of the p120 gene in endothelial cells resulted in an embryonic lethal phenotype. A series of timed mating experiments revealed that the conditional mutant animals began to exhibit lethality at developmental day E12.5, with approximately 40% lethality observed by E14.5 (Online Figure I, C) . Additionally, a fraction of the conditional mutant pups died shortly after birth. The remaining genotypic mutants survived into adulthood, with some animals exhibiting small size and failure to thrive and others exhibiting no obvious abnormalities.
To verify loss of p120 protein expression, yolk sacs were cryosectioned and examined by immunofluorescence microscopy for p120 and the endothelial adhesion molecule platelet endothelial cell adhesion molecule (PECAM)-1. 34 p120 colocalized with PECAM-1 in the vasculature of control mice ( Figure 1A through 1C) but not in vessels of conditional mutant animals ( Figure 1D through 1F) . Similar results were observed in embryonic tissue (see Online Figure II ). p120 expression in endothelial cells was also examined in surviving adult animals harboring the conditional mutant genotype (p120 flox/flox ; Cre ϩ ). Analysis of p120 expression in lung tissue of control mice ( Figure 1G through 1I) revealed extensive colocalization between p120 and PECAM-1. p120 expression could also be detected in endothelial cells of surviving mutants. Interestingly, in a mutant animal that was significantly smaller than control littermates, endothelial p120 expression was mosaic and microvascular density was dramatically reduced (Figure 1J through 1L) . In contrast, p120 expression appeared normal in genotypically mutant animals that survived into adulthood with no obvious phenotype ( Figure 1M through 1O) . The inefficient deletion of this p120 allele in some animals was also observed in the mammary gland and prostate of mice expressing Cre driven by the mouse mammary tumor virus promoter and in intestinal epithelium of mice expressing Cre using the villin promoter (Reynolds et al, unpublished) . Several other genes have been reported to exhibit mosaic deletion using Cre-loxP systems in the mouse. 35, 36 In the model system reported here, this mosaic deletion of p120 results in reduced rates of lethality. However, we examined many tens of embryos that exhibited efficient p120 ablation as assessed by immunostaining. In the phenotypic analysis described below, we summarize the phenotype representative of animals with complete endothelial p120 deletion. Importantly, genotypically mutant animals survived because of inefficient deletion of endothelial p120 rather than overcoming loss of p120 expression. From these findings, we conclude that the expression of p120 in mouse vascular endothelial cells is required for survival, and loss of p120 in endothelial cells results in embryonic lethality beginning around E12.5.
Deletion of Endothelial p120 Causes Defects in Microvascular Patterning and Hemorrhages
To define the vascular defects resulting from the ablation of the p120 gene in endothelial cells, a series of timed mating
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BrdUrd bromodeoxyuridine VE-cadherin vascular endothelial cadherin p120 p120-catenin PECAM platelet endothelial cell adhesion molecule experiments was conducted and vessel formation analyzed beginning at E9.5. PECAM-1 staining of transverse sections revealed no apparent defect in dorsal aortae lacking p120 (Online Figure II , D through F). These findings suggest that formation of large vessels by vasculogenesis proceeds normally in the absence of endothelial p120. In contrast to the dorsal aortae, intersomitic vessels form by sprouting angiogenesis. 37 Whole-mounted E9.5 embryos from six litters showed no defects in intersomitic vessel organization or vertebral arteries in mutant animals (Online Figure II , G and H). Thus, major vessels formed by both vasculogenesis and sprouting angiogenesis were indistinguishable in conditional mutant and control embryos at E9.5. Conditional mutant embryos began to exhibit lethality around E12.5 (Online Figure I) . Therefore, embryonic and extraembryonic tissue was examined at midgestational stages. At E11.5, mutant embryos displayed significant defects in placenta vasculature. In the labyrinthine layer, which contains capillaries of fetal origin, 38 . p120 is successfully ablated in conditional mutant mice but deletion is mosaic in some animals. E13.5 yolk sacs were cryosectioned and stained for p120 (B, E) and PECAM-1 (A, D) to identify blood vessels. The markers colocalized in control tissues (C), but mutant blood vessels lacked p120 (F), demonstrating that the Cre/LoxP-mediated deletion of p120 was effective. Representative blood vessels expressing p120 are marked by white arrowheads and vessels lacking p120 are indicated by blue arrowheads. Scale bar in A is 20 m. Lung tissues from young adult mice were cryosectioned and stained for p120 and PECAM-1. Representative large vessels expressing p120 are labeled with white arrowheads; blue arrowheads indicate large vessels lacking p120. Control lung tissue exhibited robust p120 expression (H) and dense microvasculature (G). p120 colocalized with the endothelial marker PECAM-1 (I). Genotypically mutant lung tissue from a physically small littermate revealed extensive p120 loss (K) with small patches of p120 expression which colocalized with PECAM-1 (L). Note reduced microvascular density and intact large vessels (J). Another genotypically mutant, surviving littermate displayed normal body size and exhibited normal p120 levels (N) and microvascular density (M and O) comparable to control animals. Scale bar in G is 100 m.
eling and expansion were compromised. In control animals, yolk sac vessels remodeled into a well-organized hierarchy of large and small vessels (Figure 2A , 2C, 2E, and 2G). In contrast, conditional p120 mutants exhibited reduced vascular branching and increased numbers of blind-ending vessels ( Figure 2I and 2J). Furthermore, morphometric analysis of vascular and avascular space revealed that mutant vessels failed to form homogeneous networks. As shown in Figure 2K , a linear relationship was apparent between vessel diameter and avascular space diameter in control animals (rϭ0.82). In contrast, mutant vessels exhibited highly variable avascular space diameter (rϭ0.27). Together, these data indicate that loss of p120 results in severe defects in vascular patterning and morphogenesis. In addition to defects in vascular organization, the absence of endothelial p120 also resulted in hemorrhages. In E12.5 embryos, hemorrhages were commonly observed in the brain ( Figure 3D and 3G, compared to 3A) and other organs (data not shown) of conditional mutant animals, and histological staining of brain sections revealed both large hemorrhages ( Figure 3E ) and leaky microvessels ( Figure 3F and 3H ). These results demonstrate that deletion of endothelial p120 leads to striking defects in mouse microvascular density and patterning as well as compromised vessel integrity in both embryonic and extraembryonic tissue.
Cadherin Expression and Pericyte Recruitment Are Decreased in p120-Null Endothelial Tissues
Previously, p120 was found to stabilize VE-cadherin expression at the plasma membrane by inhibiting cadherin endocy- Figure 2 . Yolk sac vessels of p120 conditional mutant mice reveal angiogenic remodeling defects. Whole mount yolk sacs from control and mutant embryos at various developmental time points were processed for immunofluorescence microscopy using PECAM-1 antibodies to highlight vessels (A through H). Analysis of E12.5 yolk sacs revealed decreased branch points (intersections) in mutant tissues compared to control (Pϭ0.024) (I), accompanied by an increase in blind-ending vessels (Pϭ0.015) (J). A plot of vascular versus avascular diameters in E12.5 yolk sacs revealed a lack of uniformity in blood vessel networks in mutant tissues compared to control (K, scatter plot). The ratio of vascular/ avascular diameters showed greater variability in mutant tissues (K, box plot). Scale bar is 100 m. tosis and degradation. 15 To determine whether deletion of the p120 gene caused a corresponding loss of VE-cadherin in mouse vessels, p120 and VE-cadherin colocalization were examined in embryonic vessels of E10.5 animals (Figure 4) . In control vessels, VE-cadherin colocalized extensively with p120 ( Figure 4A through 4C) . VEcadherin was also detected in p120-null vessels but appeared to be reduced compared to control vessels ( Figure  4D through 4F) . To determine whether the relative levels of cadherin were reduced in the absence of p120, we took advantage of the mosaic nature of p120 expression in a subset of embryos, thereby allowing comparison of VEcadherin levels within the same tissue section. Line scan pixel intensity plots revealed that the levels of VEcadherin were significantly reduced in vessels that were p120-null ( Figure 4G through 4I, quantified in 4M) . In contrast to VE-cadherin, no alteration in PECAM-1 levels was observed in vessels lacking p120 ( Figure 4J through 4L, quantified in 4N; see also Figure 1 ). Furthermore, we were unable to detect any differences in expression or localization of the tight junction protein claudin-5 (Online Figure IV) . N-cadherin is also expressed in endothelial cells and plays important roles in vascular development. 39, 40 Previous work has shown that p120 also regulates N-cadherin levels. 19, 31, 41 Therefore we examined N-cadherin expression levels in E11.5 mouse embryos. In control animals, vessels expressing N-cadherin were readily observed adjacent to the neural tube ( Figure 5A through 5D) . However, in mutant littermates, N-cadherin was not detected in corresponding p120-null vessels ( Figure 5E through 5H, quantified in 5I and 5J). N-cadherin has been implicated in the recruitment of pericytes to developing vessels. 40 These cells associate with endothelial cells and are important regulators of vessel remodeling and stabilization. 42 Therefore, we surveyed the degree of pericyte coverage of blood vessels in the brains of E11.5 mutant and control embryos using the pericyte antigen NG2. 40, 43 Importantly, pericyte coverage was signifi- Figure 4 . VE-cadherin levels are decreased in embryonic tissues lacking endothelial p120. E10.5 embryos were fixed, cryosectioned, and stained for p120, VE-cadherin, and PECAM-1. In control tissues, p120 (A) and VE-cadherin (B) colocalize in blood vessels (C). In conditionally mutant tissue, VE-cadherin expression is retained (E), but vascular p120 is absent (D, F). Tissue from genotypically mutant mice which exhibit mosaic p120 expression (G, I) have reduced levels of VE-cadherin in areas lacking p120 (blue arrowheads) (H), compared to areas which have positive staining for vascular p120 (white arrowheads). To verify the specificity of this effect, mosaic mutant tissues were stained for PECAM-1 (J through L). Note that PECAM-1 expression is similar in endothelial cells that express p120 (white arrowheads) and those lacking p120 (blue arrowheads). To quantify the reduction in VE-cadherin in p120-negative vessels, peak fluorescence of VE-cadherin (M) or PECAM (N) was plotted against peak fluorescence of p120. VE-cadherin levels were significantly reduced in a manner dependent on p120, whereas PECAM levels were independent of p120 levels. The fold difference of the average fluorescence intensity of VE-cadherin in p120-negative over p120-positive vessels was 0.489, compared to 1.052 for PECAM (O). (t test, PՅ0.001.) Scale bar is 20 m.
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cantly reduced in mutant embryos ( Figure 6 , compare 6B and 6E; quantified in 6G). Thus, loss of p120 leads to a substantial decrease in endothelial cadherin expression levels and is associated with reduced pericyte coverage of developing vessels.
Primary Endothelial Cells Lacking p120 Exhibit Proliferation Defects
To explore the cellular mechanisms underlying the vascular defects in the conditional p120-null mouse, primary endothelial cells were isolated from newborn p120 flox/flox ; Cre Ϫ mice. To cause p120 deletion, Cre recombinase was introduced using an adenoviral vector. 44 Following a 72-hour period to allow for turnover of previously transcribed p120, the cells were fixed and examined by immunofluorescent microscopy ( Figure 7 ). Control cells infected with empty adenoviral vector retained p120 expression ( Figure 7A and 7G) . Additionally, these cells also expressed both VE-cadherin ( Figure  7B ) and PECAM-1 ( Figure 7H ), confirming the endothelial identity of the cells. Expression of Cre resulted in near complete ablation of p120 ( Figure 7D and 7J) . Furthermore, loss of p120 resulted in a striking reduction in VE-cadherin ( Figure 7E ) but not PECAM-1 levels ( Figure 7K ). This result was confirmed by western blot analysis ( Figure 7M ). In addition to expression of adhesion molecules, cultured mouse endothelial cells were also examined for barrier function and proliferation potential. For barrier studies, monolayers of endothelial cells from p120 flox/flox ; Cre Ϫ mice were cultured on filter membranes and infected with adenovirus to express either GFP or Cre. Diffusion of Texas red-labeled dextran across the cell layers was monitored as an assay of barrier function ( Figure 7N ). Although a slight increase in dextran diffusion was observed in some experiments, we were unable to demonstrate a statistically significant change in dextran flux in p120-null cells compared to controls. However, endothelial cells lacking p120 exhibited significantly reduced growth rates ( Figure 7O ). These results suggest a role for p120 in endothelial proliferation.
Previous studies have shown that VE-cadherin plays a key role in endothelial growth control, [45] [46] [47] and more recent studies have shown that p120-null keratinocytes exhibit a growtharrested phenotype. This latter study also implicated p120 inhibition of RhoA as the mechanism underlying this mitotic Figure 5 . N-cadherin is absent in endothelial cells lacking p120 in vivo. Cryosectioned E11.5 embryos were fixed and stained for N-cadherin, VE-cadherin (to identify blood vessels), and p120 (to verify its absence in mutant endothelial tissue). In the area surrounding the neural tube, N-cadherin-positive blood vessels were frequently seen in control mice (A through D). Corresponding vessels of mutants lacking vascular p120 also lacked N-cadherin (E through H). N-cadherin expression was quantified in mutant and control blood vessels relative to p120 as described for VE-cadherin (see Figure 4) . The average N-cadherin fluorescence intensity of p120-positive vessels was more than 2.5 times that of p120-negative vessels (J). (Mann-Whitney Rank Sum, PՅ0.001). Scale bar is 20 m. Cryosections (12-m) were cut from the brains of E11.5 mice and stained for NG2 to identify pericytes, VE-cadherin to identify blood vessels, and p120. Representative fields are shown for control (A through C) and mutant (D through F) mice. To quantify pericyte coverage of blood vessels, multiple images were collected from a series of 2 mutant and 3 control mice from the same litter. Five hundred individual vessels from each population were scored based on their contact with pericytes. The percentage pericyte coverage per field was compared between mutant and control (G). Control vessels had pericyte coverage of nearly 83% compared to only 58% pericyte coverage in mutant vessels (t test, PՅ0.001). Scale bar is 100 m.
defect. 48 To determine whether the endothelial growth defect in p120-null cells is RhoA-or VE-cadherin-dependent, exogenous p120 and VE-cadherin were reexpressed in p120-null primary endothelial cells. In addition to wild-type p120 1A, a p120 mutant unable to inhibit RhoA (p120 4A K622,628A) 49 was used to determine whether inhibition of RhoA is involved in regulating VE-cadherin expression levels and/or endothelial proliferation. Similar to the results shown in Figure 7 , loss of endogenous p120 resulted in significantly decreased VE-cadherin levels ( Figure 8C and 8D) and a corresponding decrease in endothelial proliferation as measured by bromodeoxyuridine (BrdUrd) uptake ( Figure  8K ). Expression of exogenous wild-type p120 1A rescued both VE-cadherin levels ( Figure 8E and 8F) and BrdUrd uptake. Furthermore, VE-cadherin levels were also restored by the Rho-uncoupled p120 mutant (p120 4A K622,628A). Interestingly, the Rho-uncoupled mutant also rescued the proliferation defect observed in p120-null cells, suggesting that decreased VE-cadherin expression underlies the reduction in proliferation. Consistent with this interpretation, exogenous expression of VE-cadherin in p120-null cells also restored BrdUrd uptake. These studies indicate that p120 regulates endothelial proliferation through a cadherindependent mechanism.
Discussion
The findings reported here demonstrate for the first time a central and indispensable role for p120-catenin in mammalian vascular development. Deletion of endothelial p120 results in downregulation of both VE-cadherin and N-cadherin, as well as decreased endothelial proliferation and reduced pericyte coverage of developing microvessels. These alterations are associated with microvascular patterning defects, hemorrhaging and midgestational embryonic lethality.
One of the most striking phenotypes resulting from the selective inactivation of the p120 gene in endothelial cells is the failure of microvessels to properly pattern. The earliest defects in vessel patterning were observed in the placenta at E11.5, where vascular density in the labyrin- thine was markedly reduced (Online Figure III, A through  D) . Analysis of vascular patterning in the yolk sac at different developmental stages suggests that microvessels form normally, but then either regress or are unable to expand with tissue growth (Figure 2 ). Morphological analysis of yolk sac microvessels revealed decreased vessel branching and increased avascular space ( Figure 2I through 2K). These observations suggest that microvessel growth into avascular areas is insufficient to keep pace with the rapid midgestational growth of the embryo. Consistent with this notion, deletion of p120 in cultured endothelial cells resulted in significantly reduced endothelial cell growth and proliferation (Figures 7 and 8) . It is likely that the inability of endothelial cells to proliferate efficiently in the absence of p120 explains, at least partially, the defect in vascular density observed in vivo.
In addition to microvascular patterning defects, mutants lacking endothelial p120 also exhibited hemorrhaging, particularly in the brain. Tight junction proteins are essential to maintaining the blood-brain barrier, 50 and recent studies have implicated VE-cadherin in the transcriptional regulation of claudin-5, 51 suggesting that alterations in tight junctions may also underlie some of the p120-null defects. However, we were unable to demonstrate any significant alterations in the expression or localization of claudin-5 in the absence of endothelial p120 (Online Figure IV) . In addition to tight junctions, pericytes associate with small vessels and have been shown to regulate capillary diameter and vascular permeability in the brain. 52 Loss of pericytes in the developing mouse results in lethality attributable to microvascular hemorrhaging and edema. 42 Importantly, deletion of p120 resulted in reduced pericyte coverage in mutant vessels in the brain ( Figure 6 ). These findings suggest that reduced pericyte recruitment, rather than alteration of tight junctions, is the underlying cause of brain hemorrhaging in the p120 mutant embryos.
Pericyte recruitment and endothelial growth are both regulated by endothelial cadherins. 6, 39, 40 Previous studies have demonstrated that a central function of p120 is to posttranslationally stabilize cadherins. 53 In cultured endothelial cells, knockdown of p120 using siRNA leads to VE-cadherin endocytosis and degradation. 18 In the present study, we observed that VE-cadherin levels were significantly reduced in vessels lacking p120 (Figure 4) , demonstrating that p120 also regulates VE-cadherin levels in vivo. Similarly, in endothelial cells isolated from p120 flox/ flox; Cre Ϫ mice, deletion of the p120 gene on expression of Cre recombinase leads to a significant reduction in both p120 and VE-cadherin ( Figure 7 ). These cells also exhibit dramatically reduced proliferation (Figure 8 ). Loss of endothelial proliferation during embryonic development provides a reasonable explanation for the loss of microvascular density observed in vivo (Figure 2 ; Online Figure  III) . A number of studies have implicated VE-cadherin in regulating endothelial proliferation. 54, 55 Consistent with these previous studies, the endothelial proliferation defect of p120-null endothelial cells could be rescued by expression of exogenous VE-cadherin (Figure 8 ), suggesting that reduced VE-cadherin levels play an important role in both endothelial proliferation and in the loss of vessel density in the mutant embryos. Similar to VE-cadherin, levels of N-cadherin are also reduced in p120-null vessels ( Figure  5 ). N-cadherin is required for vascular development and has been implicated in pericyte recruitment to developing vessels. 39, 40 Together, these results suggest that the reduction in VE-cadherin and N-cadherin on deletion of endothelial p120 contributes to the reduced microvascular density and hemorrhaging that characterizes these mutants. In addition to regulating cadherin endocytosis, p120 inhibits RhoA activity. Furthermore, recent studies indicate that RhoA inhibition can rescue proliferation defects observed in p120-null keratinocytes. 48 To determine whether RhoA inhibition is important for regulating VEcadherin levels and/or endothelial cell proliferation, we used a p120 mutant that associates with cadherin but is unable to inhibit RhoA. This approach revealed that decreased endothelial VE-cadherin levels and reduced proliferation could both be rescued by re-expression of wild type p120 1A or a mutant p120 defective in RhoA inhibition (Figure 8 ). These observations are consistent with our recent report that p120 inhibits cadherin endocytosis in a RhoA-independent manner. 17 Furthermore, the ability of the Rho-uncoupled mutant to rescue both VEcadherin levels and endothelial proliferation further couples loss of VE-cadherin to the proliferation defect in the p120-null endothelial cells.
Previous studies demonstrated that VE-cadherin null animals die embryonically because of severe vascular remodeling defects. 47, 56 However, heterozygous mice in which VE-cadherin protein levels were reduced by approximately 50% were phenotypically normal. In the absence of p120, VE-cadherin levels in vivo were reduced by approximately 50% as assessed by fluorescence intensity measurements of control and p120-null vessels ( Figure  4M ). However, it is important to note that deletion of p120 results in reduced levels of both N-cadherin and VE-cadherin, both of which are required for vascular development. 39, 47, 56 In addition, a recent study using a zebrafish model demonstrated that even a modest reduction in VE-cadherin resulted in brain hemorrhaging. 29 The severity of the phenotype correlated with the degree to which VE-cadherin levels were reduced, suggesting that loss of VE-cadherin may also contribute directly to the hemorrhaging observed in our conditional p120 mutant animals. Lastly, it is also likely that loss of p120 compromises VE-cadherin adhesive functions independently from control of cadherin expression levels. Likely possibilities include dysregulation of Rho-family GTPases. 57 Consistent with this notion, VE-cadherin was recently shown to reduce vessel sprouting by suppressing Rac1 activity and enhancing actomyosin contractility. 58 Given the role of p120 in regulating Rho-family GTPases, this activity of p120 may also contribute to some aspects of endothelial cell function in developing vessels, including tubule formation and barrier function. Additional mouse genetic models and other approaches will be required to distinguish between these possibilities. Lastly, we should note that the Tie-2 promoter has been shown to be active in hematopoietic cells. Although it is formally possible that functions of p120 are important in this lineage, the data presented here provide clear evidence for a crucial role of p120-catenin in endothelial cells, both in vivo and in vitro.
Together, these findings demonstrate a central role for p120 catenin in vascular integrity, microvascular patterning, and endothelial proliferation.
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